chủng sản xuất để phát triển vắc xin Cúm mùa trên hai dòng tế bào PMKc và MDCK.
Tài liệu tham khảo Tiếng Việt
1. Nguyễn Thu Vân, Hoàng Thuỷ Nguyên, Nguyễn Tuyết Nga, Đinh Thuý Vân, Nguyễn Kim Dung, Nguyễn Hoàng Mai (2006), “Nghiên cứu thích ứng chủng virút RGH5N1 trên tế bào thận khỉ tiên phát”, TC Y học thực hành, số 7.
Tiếng Anh
2. Connor R.J., Kawaoka Y., Webster R.G., Paulson J.C. (1994), “Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates”, Virology, 205(1), pp. 17-23.
3. Frank, A. L., R. B. Couch, C. A. Griffits, B. D. Baxter. (1979), “Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses”, J. Clin. Microbiol, 10, pp. 32-36.
4. Furesz J., Fanok A., Contreras. G. and Becker B. (1989), “Tumorogenicity testing of various cell substrates for production of biologicals”, Dev. Biol. Stand., 70, pp. 233-243.
5. Gambaryan A.S., Karasin A.I., Tuzikov A.B., et al. (2005), “Receptor- binding properties of swine influenza viruses isolated and propagated in MDCK cells”, Virus Res., 114 (1-2), pp. 15-22.
6. Gorman O.T., Bean W.J., Kawaoka Y., Donatelli I., Guo Y., Webster R.G. (1991), “Evolution of influenza viurs nucleoprotein genes: implications for the origin of H1N1 human and classical swine viruses”, J. Virol., 65, pp. 3704-3714.
7. Govorkova E.A., Murk G., Meignier B., De Taisne, C, Webster R.G. (1996), “African Green Monkey Kidney (Vero) cells provide an alternative host cell system for Influenza A and B virus”, J. Viral., 70, pp. 5519-5524. 8. Grose G.J., Otto E.E., Powers D.C., Chambers G.W., Eickhoff C.S., Newman
F.K. (1996), “Introdution of mucosal antibodies by live attenuated and inactivated influenza viurs vaccines in the chronically ill elderly”, J. Infect. Dis., 173, pp. 285-290.
9. Hampson AW (1999), “Epidemiological data on influenza in Asian countries”, Vaccine, 17, pp. 19-23.
10. Hang L.K. Nguyen, Reiko Saito, Ha K. Ngiem, Makoto Nishikawa, Yugo Shobugawa, Doan C. Nguyen, Long T. Hoang, Lien P. Huynh, Hiroshi Suzuki (2007), “Epidemiology of influenza in Hanoi, Vietnam, from 2001 to 2003”, Journal of Infection, 55, pp. 58-63.
11.Hilleman M. (2002), "Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control", Vaccine,20, pp. 3068-3087.
12. Hinshaw V.S., Webster R.G., Easterday B.C., Bean W.J. (1981), “Replication of avian influenza viruses in mammals”, Infect. Immun., 34, pp. 354-361. 13. Horaud F. (1992), “Absence of viral sequences in the WHO-Vero cell bank:
a collaborative study”, Develop. Biol. Stand., 76, pp. 43-46.
14. Katz J.M., Webster R.G. (1989), “Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs”, J Infect Dis, 160(2), pp. 191-198.
15. Kaverin N. V., Webster R.G (1995), “Impairment of Multicycle Influenza Virus Growth in Vero (WHO) Cells by Loss of Trypsin Activity”,
Journal of Virology, pp. 2700-2703.
16. Klenk H.D., Rott R., et al. (1975), Activation of influenza A viruses by trypsin treatment, Virology, 68, pp. 426-39.
17. Lau S.C., Scholtissek C (1995), “Abortive infection of Vero cells by an Influenza A virus (FPV)”, Virology, 212, pp. 225-231.
18. Lazarowitz S.G., Choppin P.W. (1975), Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide, Virology, 68, pp. 440-454.
19. Li C.K., Choi B.C., Wong T.W. (2006), “Influenza-related deaths and hospitalizations in Hong Kong: a subtropical area”, Public Health, 120, pp. 517-524.
20. Lu H., Castro A.E., et al. (2003), “Survival of avian influenza virus H7N2 in SPF chickens and their environments”, Avian Dis, 47, pp. 1015-1021. 21. Montagnon B.J., Fanget B., Nicholas A.J. (1987), “The largescale cultivation
of Vero cells in microcarrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine”, Dev. Biol. Stand., 47-55. 22. Nakamura K., Homma M. (1981), “Protein synthesis in Vero cells abortively
infected with Influenza B virus”, J. Gen. Viral., 56, pp. 199-202.
23. Nerome K., Kanegae Y., Shortridge K.F., Sugita S., Ishida M. (1995), “Genetic analysis of porcine H3N2 viruses originating in southern China”, J. Gen. Virol., 76, pp. 1247-1249.
24. Nuss J.M., Whitaker P.B., Air G.M (1993), “Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase. Proteins”, 15, pp. 121-32.
25.Potter C.W. (2001), "A History of Influenza", Journal of Applied Microbiology,91(4), pp. 572-579.
26.Reina J., Fernandez-Baca V., et al. (1997), “Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture”, J. Clin Microbiol, 35(7), pp. 1900-1901.
27. Rott R., M. Orlich, Kienk H.D., Wang M. L. (1984), “Studies on the adaptation of influenza viruses to MDCK cells”, The EMBO Journal, 3(13), pp. 3329-3332. (adsbygoogle = window.adsbygoogle || []).push({});
28. Rott R., Reinacher M., Orlich M. and Klenk H..D. (1980), “Cleavability of hemagglutinin determines spread of avian influenza viruses in the chorioallantoic membrane of chicken embryo”, Arch. Viral., 65, pp. 123- 133.
29. Rowe, P.M. (1995), “Pandemic influenza (un)preparedness described”, The Lancer , 346, 1699.
30. Schepetiuk S. K., T. Kok (1993), “The use of MDCK, MEK and LLCMK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens”, J. Virol. Methods, 42, pp. 241-250.
31. Simmerman J.M., Chittaganpitch M., Erdman D., Sawatwong P., Uyeki T.M., Dowell S.F. (2006), “Field performance and new uses of rapid influenza testing in Thailand”, Int J Infect Dis., 24, pp. 4417-4426.
32. Stallknecht D.E., et al. (1990), “Persistence of avian influenza viruses in water”, Avian Diseases, 34, pp. 406-411.
33. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., Looby D. (2001), “Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains”, Vaccine, 19, pp. 3444-3450.
34. Tulip W.R., Varghese J.N., et al. (1992), “Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex”, J Mol Biol, 227, pp. 122-148.
35. Vincent Falquet J.C., Peyron L., Souvras M., Moulin J.C., Tektoff J. and Patet (1989), “J. Qualification of working cell banks for the Vero cell line to produce licensed human vaccines”, Dev. Biol. Stand., 70, pp. 153-l 56. 36. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawoaka Y.
(1992), “Evolution and ecology of influenza A viruses”, Microbio. Rev, 56, pp. 152-179.
37. White J.M. (1992), Membrane fusion, Science, 258, pp. 917-924. 38. WHO (2001), Weekly epidemiological record, 76, pp. 357-360.
39. WHO (2002), Weekly epidemiological record, 77, pp. 358-361. 40. WHO (2003), Weekly epidemiological record, 78, pp. 393-396. 41. WHO (2004), Weekly epidemiological record, 79, pp. 385-388. 42. WHO (2008), Weekly epidemiological record , 83, pp. 365-372.
43. Yamashita M., Krystal M., Fitch W.M., Palese P. (1987), “Influenza B virus evolution: cocirculating lineages and comparison of evolutionary pattern with those of influenza A and C viruses”, Virology, 163, pp. 112-122.